ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,325.18
-0.34%
Brent Oil
82.075
-0.06%
Bitcoin
66,341.35
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oasmia Pharmaceuticals AB (OASM)

  7. Oasmia Pharmaceuticals AB (OASM) News

Oasmia Pharmaceuticals AB (OASM)

Oasmia Pharmaceuticals AB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OASM
DateTimeSourceHeadlineSymbolCompany
07/03/202213:35Business WireCORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals TransactionNASDAQ:OASMOasmia Pharmaceuticals AB
07/03/202212:20Business WireWhiting and Oasis to Combine in $6.0 Billion Merger of Equals TransactionNASDAQ:OASMOasmia Pharmaceuticals AB
27/11/201914:54Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OASMOasmia Pharmaceuticals AB
21/11/201914:41Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:OASMOasmia Pharmaceuticals AB
23/08/201915:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OASMOasmia Pharmaceuticals AB
23/08/201913:01Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:OASMOasmia Pharmaceuticals AB
21/08/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
15/08/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
13/08/201911:03Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...NASDAQ:OASMOasmia Pharmaceuticals AB
13/08/201911:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OASMOasmia Pharmaceuticals AB
08/08/201921:15Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OASMOasmia Pharmaceuticals AB
06/08/201921:31Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
01/08/201921:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
09/07/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
09/07/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
02/07/201921:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
28/06/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
26/06/201921:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
25/06/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
20/05/201916:36Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
12/04/201921:40Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/04/201921:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
01/04/201921:10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
01/04/201921:09Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
27/03/201920:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
25/03/201920:33Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
20/03/201910:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
06/03/201921:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
04/03/201921:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
01/03/201921:09Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:OASMOasmia Pharmaceuticals AB
 Showing the most relevant articles for your search:NASDAQ:OASM

Your Recent History

LSE
TW.
Taylor Wimpey
LSE
SVE
Starvest
LSE
CPL
LSE
RBD
Reabold Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved